Follow the Medivir Aktiebolag share price and the full insider trade history of the company, a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Medivir Aktiebolag has logged 4 reports. Market capitalisation: €1.1bn. The latest transaction was disclosed on 19 June 2026 (Purchase). Among the most active insiders: Patrik Norgren. The full history is free.
4
Insider Decl.
0
Thresholds
€46,982
4 ops.
Buy Volume
·
0 ops.
Sell Volume
33Σ signal
Buys €46,982· Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3,750 shares@ SEK 7.00100.0% of flowBTA (betald tecknad aktie)FI:A001P849-1
Ideal exit: 31 Oct 2021 (T+270)
4 of 4 declarations
About Medivir Aktiebolag
Medivir Aktiebolag is a Swedish biopharmaceutical company focused on developing antiviral treatments. It is listed on the Stockholm Stock Exchange under the ticker XSTO.